Evasc Neurovascular Announces the New eCLIPs Bifurcation Flow Diverter
Evasc Neurovascular is proud to announce the third generation of its eCLIPs™ device, the eCLIPs Bifurcation Flow Diverter.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211019006102/en/
The new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher than the existing eCLIPs devices. As a result, the new eCLIPs Bifurcation Flow Diverter does not require coiling and provides for the same unique neck bridging delivery. The new eCLIPs Bifurcation Flow Diverter can cover up to a 6mm neck length. The eCLIPs Bifurcation Flow Diverter also simplifies deployment with greatly reduced delivery times.
“We’re excited to see the latest innovation in Evasc Neurovascular’s eCLIPs devices, which will lead to better outcomes for patients and remarkable device delivery time—usually within 10 minutes,” said Leif Sorensen, Neuroradiology, Aarhus University Hospital, Denmark.
The newest generation of eCLIPs is innovated for more effective treatment of intracranial bifurcation aneurysms with a shapeable delivery wire, a smaller size that is compatible with 0.021” and 0.027” ID microcatheters, and electrolytic detachment.
“We have listened to the experts in the neuro field and developed an improved version that is smaller and easier to use. This will allow treatment for a wider range of aneurysms and shorten delivery times,” said Dr. Donald Ricci, President and Chief Executive Officer of Evasc Neurovascular.
“The previous version showed exceptional outcome due to the eCLIPs implant’s ability to bridge the neck of the aneurysm and to create a flow diversion effect. This new and improved version retains these favourable characteristics and also allows eCLIPs to gain access to smaller and more distant vessels within the cerebral anatomy,” added Dr. Ricci.
About the eCLIPs Aneurysm Treatment System
eCLIPs is a non-tubular endovascular device currently targeted for use in challenging wide-neck bifurcations, using technology designed to treat 95% of bifurcation aneurysm cases. The unique eCLIPs design provides not only coil retention, but also flow diversion at the neck. eCLIPs avoids dangerous entry into the dynamic, fragile environment of the aneurysm sac while leaving side branches unencumbered and providing a platform for endothelial growth across the bifurcation neck.
About Evasc Neurovascular
Evasc Neurovascular is a privately-held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms. Evasc Neurovascluar is headquartered in Vancouver, Canada.
Visit Evasc Neurovascular at www.evasc.com .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-ENTERSEKT/ACCEL-KKR9.12.2021 10:02:57 CET | Press release
Accel-KKR Backs Entersekt, A Leader in Frictionless Authentication Solutions
IKOULA9.12.2021 10:02:06 CET | Press release
IKOULA Simplifies the Management of Large-Scale Cloud Infrastructure with CloudStack and XCP-ng
EUNETWORKS-HOLDINGS-LTD9.12.2021 09:32:13 CET | Press release
euNetworks Refinances Existing Debt and Secures Additional Sustainability-linked Debt Funding Commitment to Drive Continued Growth
ADVA9.12.2021 09:20:09 CET | Press release
ADVA boosts PNT resilience with new software release
AEROGEN9.12.2021 08:05:06 CET | Press release
Aerogen® and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery
ATTENSI9.12.2021 08:02:09 CET | Press release
Attensi and SAP SuccessFactors Enter into a Strategic Partnership to Revolutionize Learning and Development
MD-ROBOTIC-RESEARCH9.12.2021 07:02:04 CET | Press release
Robotic Research Announces $228 Million Series A Funding Round to Scale Autonomous Technology Commercially
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom